Safflower oil, which contains no ALA, ate the men but observed no effect of lowering blood pressure. The ALA high concentration contained in linseed oil is therefore responsible for the effect of lowering blood pressure. ALA occurs not only in vegetable oils and fish oil. Flaxseed oil has the highest percentage of ALA of all naturally occurring oils. Now, linseed oil because of its high percentage of ALA is very sensitive and can be destroyed quickly and easily.

To prevent this, linseed oil must be specially prepared and ideally filled into capsules. Special pure vegetable capsules, which are also suitable for vegetarians, are the Vegicaps where linseed oil as OmVitum is offered. Each Vegicap contains 500mg of highly purified linseed oil with about 300mg of ALA. OmVitum is offered along with antioxidant vitamins in CorVitum as a combination Pack of CardioPlus. CardioPlus is a preparation, the both oxidative stress and also the inflammatory processes in the Focus has and consists of CorVitum and OmVitum.

The documentation in the background of this products shows that antioxidants such as CorVitum can be used to prevent progression of atherosclerosis and cheap affect the purely plant-based Omega-3 fatty acid ALA as in OmVitum inflammatory mediators. CardioPlus (PZN 0265193) offers the opportunity, easily and cost-effectively to use evidence-based health care for heart and vessels the health-conscious people. For the meaningful longer-term application of CardioPlus special 3 month packs (PZN 0265218) and 6-month packs (PZN 0265230) are available. CardioPlus is available in pharmacies and selected health centers. Due to the unique composition of the products of Navitum Pharma not by other, seemingly similar products are interchangeable. Every pharmacy can order CardioPlus without extra effort directly shipping to customers. As a special service, Navitum Pharma offers for health-conscious people also the shipping free direct procurement of the company by telephone on 0611 58939458 map. Source: Defilippis AP et al. Curr treat options Cardiovasc Med 2010 Aug;12(4):365-80. landmark k et al. Tidsskr nor Laegeforen. 2006 Nov 2;126(21):2792-4. Paschos GK, et al. EUR J Clin Nutr. 2007 Jan 31; Ye, Z. et al. EUR J Cardiovasc Prev Rehabil. 2008; 15(1): 26-34; Myint PK. Et al. Am J Clin Nutr. 2008; 87(1): 5-7; Platinga Y et al. Am J Hypertens 2007; 20(4): 392-7 Salonen RM et al. circulation. 2003 Feb 25;107(7):947-53. contact: Navitum Pharma GmbH Dr. Gerhard Klages at the water tower 29 65207 Wiesbaden Tel: 0611-58939458 FAX: 0611-9505753 E-Mail: Web: